TRACON Pharmaceuticals Analysis
| TCONDelisted Stock | USD 1.60 0.55 52.38% |
TRACON Pharmaceuticals is overvalued with Real Value of 1.52 and Hype Value of 1.6. The main objective of TRACON Pharmaceuticals otc analysis is to determine its intrinsic value, which is an estimate of what TRACON Pharmaceuticals is worth, separate from its market price. There are two main types of TRACON Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The TRACON Pharmaceuticals otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
TRACON |
TRACON OTC Stock Analysis Notes
The company recorded earning per share (EPS) of 106.4. TRACON Pharmaceuticals last dividend was issued on the 8th of November 2019. The entity had 1:20 split on the 10th of April 2024. TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California. Tracon Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.The quote for TRACON Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about TRACON Pharmaceuticals contact the company at 858 550 0780 or learn more at https://www.traconpharma.com.TRACON Pharmaceuticals Investment Alerts
| TRACON Pharmaceuticals is not yet fully synchronised with the market data | |
| TRACON Pharmaceuticals may become a speculative penny stock | |
| TRACON Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.04 M. Net Loss for the year was (3.59 M) with loss before overhead, payroll, taxes, and interest of (13.89 M). |
TRACON Pharmaceuticals Upcoming and Recent Events
Earnings reports are used by TRACON Pharmaceuticals to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
TRACON Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TRACON Pharmaceuticals's market, we take the total number of its shares issued and multiply it by TRACON Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.TRACON Profitablity
TRACON Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase TRACON Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, TRACON Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, TRACON Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of TRACON Pharmaceuticals' profitability requires more research than a typical breakdown of TRACON Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (32.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $32.12. TRACON Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TRACON Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on TRACON Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TRACON Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Charles Theuer over six months ago Acquisition by Charles Theuer of 3500 shares of TRACON Pharmaceuticals at 0.1333 subject to Rule 16b-3 | ||
Charles Theuer over six months ago Acquisition by Charles Theuer of 518300 shares of TRACON Pharmaceuticals at 0. subject to Rule 16b-3 | ||
Charles Theuer over six months ago Acquisition by Charles Theuer of 4500 shares of TRACON Pharmaceuticals at 1.85 subject to Rule 16b-3 | ||
Charles Theuer over a year ago Purchase by Charles Theuer of 99 shares of TRACON Pharmaceuticals | ||
Twiford J Rainer over a year ago Acquisition by Twiford J Rainer of 18000 shares of TRACON Pharmaceuticals subject to Rule 16b-3 | ||
Charles Theuer over a year ago Purchase by Charles Theuer of 200 shares of TRACON Pharmaceuticals | ||
Charles Theuer over a year ago Acquisition by Charles Theuer of 332000 shares of TRACON Pharmaceuticals subject to Rule 16b-3 |
TRACON Pharmaceuticals Outstanding Bonds
TRACON Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. TRACON Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most TRACON bonds can be classified according to their maturity, which is the date when TRACON Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| TOYOTA 365 18 AUG 25 Corp BondUS89236TKF11 | View | |
| TOYOTA 445 29 JUN 29 Corp BondUS89236TKD62 | View | |
| TOYOTA 395 30 JUN 25 Corp BondUS89236TKC89 | View | |
| TOYOTA 2362 25 MAR 31 Corp BondUS892331AN94 | View | |
| TOYOTA 305 22 MAR 27 Corp BondUS89236TJZ93 | View | |
| TOYOTA 24 13 JAN 32 Corp BondUS89236TJW62 | View | |
| US892356AA40 Corp BondUS892356AA40 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View |
About TRACON OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how TRACON Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling TRACON shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as TRACON Pharmaceuticals. By using and applying TRACON OTC Stock analysis, traders can create a robust methodology for identifying TRACON entry and exit points for their positions.
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California. Tracon Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding TRACON Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in TRACON OTC Stock
If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |